Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival of Patients With Primary Prophylactic ICD Indication, Provided With Intensified Care After 1st ICD Therapy

NCT00619593 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.

NCT NCT00619593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival of Patients With Primary Prophylactic ICD Indication, Provided With Intensified Care After 1st ICD Therapy
Lead sponsor
Biotronik SE & Co. KG
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2014
Enrollment
504 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

primary prevention, sudden cardiac death, tachycardia, ventricular